They're giving it the go-ahead despite questions about what how it might affect people with lung disease or those exposed to secondhand smoke. That makes me a bit nervous, because those and other concerns exist, too.
However, in theory, studies on long-term effects of Exubera are proposed to go until 2019, Yahoo reports.
"We understand the need to assess the long-term effects on pulmonary function," Dr. Neville Jackson of Pfizer told the press.
Well, that sounds promising -- at at least they're looking into it further to find out about more side effects.
Frankly, I'm always puzzled by stories that purport to help people with diabetes -- and yet, you find NO mention of the role the patient plays in all of this!